A mathematical model for prediction of drug molecule diffusion across the blood-brain barrier

被引:7
作者
Burns, J
Weaver, DF
机构
[1] Dalhousie Univ, Dept Med Neurol, Halifax, NS B3H 4J3, Canada
[2] Dalhousie Univ, Dept Chem, Halifax, NS B3H 4J3, Canada
[3] Dalhousie Univ, Dept Biomed Engn, Halifax, NS, Canada
[4] Univ Toronto, Dept Math, Toronto, ON, Canada
关键词
D O I
10.1017/S0317167100003759
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Predicting the ability of drugs to enter the brain is a longstanding problem in neuropharmacology. The first step in creating a much-needed computational algorithm for predicting whether a drug will enter brain is to devise a rigorous mathematical model. Methods: Employing two experimental measures of blood-brain barrier (BBB) penetrability (brain/plasma ratio and the brain-uptake index) and 14 theoretically derived biophysical predictors, a mathematical model was developed to quantitatively correlate molecular structure with ability to traverse the BBB. Results: This mathematical model employs Stein's hydrogen bonding number and Randic's topological descriptors to correlate structure with ability to cross the BBB. The final model accurately predicts the ability of test molecules to cross the BBB. Conclusions: A mathematical method to predict blood-brain barrier penetrability of drug molecules has been successfully devised. As a result of bioinformatics, chemoinformatics and other informatics-based technologies, the number of small molecules being developed as potential therapeutics is increasing exponentially. A biophysically rigorous method to predict BBB penetrability will be a much-needed tool for the evaluation of these molecules.
引用
收藏
页码:520 / 527
页数:8
相关论文
共 53 条
[21]   LOW CENTRAL-NERVOUS-SYSTEM PENETRATION OF N-2,N-4,N-6-TRIHYDROXYMETHYL N-2,N-4,N-6-TRIMETHYLMELAMINE (TRIMELAMOL) - A CYTOTOXIC S-TRIAZINE WITH REDUCED NEUROTOXICITY [J].
JUDSON, IR ;
RUTTY, CJ ;
ABEL, G ;
GRAHAM, MA .
BRITISH JOURNAL OF CANCER, 1986, 53 (05) :601-606
[22]  
KERBER CW, 1983, AM J NEURORADIOL, V4, P317
[23]   PHARMACOKINETICS OF ROLIPRAM IN THE RHESUS AND CYNOMOLGUS MONKEYS, THE RAT AND THE RABBIT - STUDIES ON SPECIES-DIFFERENCES [J].
KRAUSE, W ;
KUHNE, G .
XENOBIOTICA, 1988, 18 (05) :561-571
[25]   CEREBRAL-CIRCULATION AND NOREPINEPHRINE - RELEVANCE OF BLOOD-BRAIN-BARRIER [J].
MACKENZIE, ET ;
MCCULLOCH, J ;
OKEANE, M ;
PICKARD, JD ;
HARPER, AM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1976, 231 (02) :483-488
[26]  
MONTGOMERY DC, 1992, INTRO LINEAR REGRESS, P103
[27]   VANDERWAALS VOLUME FRAGMENTAL CONSTANTS [J].
MOTOC, I ;
MARSHALL, GR .
CHEMICAL PHYSICS LETTERS, 1985, 116 (05) :415-419
[28]  
NAGAHAMA S, 1984, J PHARMACOL EXP THER, V228, P370
[29]   BETA-ADRENOCEPTOR BLOCKERS AND THE BLOOD-BRAIN-BARRIER [J].
NEILDWYER, G ;
BARTLETT, J ;
MCAINSH, J ;
CRUICKSHANK, JM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (06) :549-553
[30]  
NELDER JA, 1991, GEN LINEAR MODELS, P323